A Virtual Reality View: Pediatric & Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Program overview: While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets, reviewing severity and diagnosis of AD, and discussing the clinical profiles of existing and emerging agents, with a focus on treatment individualization.

Host: Med Learning Group. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Location: Sheraton Denver, Majestic Ballroom

Date: Friday, March 20

Registration time: 6:30 p.m.

Program Time: 7-8 p.m.

Pre-register here or call 207-406-4248.

Top